Abstract 186 Table 1

OR: odds ratio; OS: overall survival; HR: hazard ratio; *number of patients included into the clear cell cohort was too small to allow meaningful OS analyses

High gradeLow gradeMucinousClear cell
n5,15629921971
TR0 (%)32.7%52.2%31.1%49.3%
TR1-10 (%)31.7%26.1%26.0%21.1%
OR (95%CI) for TR01 (reference)1.84 (1.44–2.36)0.95 (0.70–1.29)1.69 (1.03–2.79)
Deaths n (%)3,122 (60.6%)115 (38.5%)155 (70.8%)46 (64.8%)
OS HR(95%CI) TR0 vs TR>100.48 (0.43–0.52)0.39 (0.24–0.64)0.64 (0.40–1.03)*
OS HR(95%CI) TR1-10 vs TR>100.91 (0.84–0.99)0.87 (0.52–1.44)1.09 (0.71–1.67)*
OS HR(95%CI) TR0 vs TR1-100.52 (0.48–0.58)0.45 (0.28–0.73)0.59 (0.36–0.96)*
OS HR(95%CI) TR0 vs TR>00.50 (0.46–0.54)0.42 (0.28–0.64)0.62 (0.40–0.95)*